Education
About Us
Working with TipRanks
Follow Us
CK Life Sciences International (Holdings), Inc. (HK:0775)
:0775
RESEARCH TOOLSreports
0775 Stock Chart & Stats
Day’s Range― - ―
52-Week RangeHK$0.33 - HK$1.10
Previous CloseN/A
Volume680.00K
Average Volume (3M)8.05M
Market Cap
HK$8.94B
Enterprise ValueHK$9.47B
Total Cash (Recent Filing)HK$571.21M
Total Debt (Recent Filing)HK$6.10B
Price to Earnings (P/E)―
Beta0.78
Next Earnings
Aug 12, 2025EPS EstimateN/A
Last Dividend Ex-Date
May 23, 2023Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding9,611,072,000
10 Day Avg. Volume16,739,091
30 Day Avg. Volume8,049,741
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
CK Life Sciences International (Holdings), Inc. News
0775 FAQ
What was CK Life Sciences International (Holdings), Inc.’s price range in the past 12 months?
CK Life Sciences International (Holdings), Inc. lowest stock price was HK$0.33 and its highest was HK$1.10 in the past 12 months.
What is CK Life Sciences International (Holdings), Inc.’s market cap?
CK Life Sciences International (Holdings), Inc.’s market cap is HK$8.94B.
When is CK Life Sciences International (Holdings), Inc.’s upcoming earnings report date?
CK Life Sciences International (Holdings), Inc.’s upcoming earnings report date is Aug 12, 2025 which is in 8 days.
How were CK Life Sciences International (Holdings), Inc.’s earnings last quarter?
CK Life Sciences International (Holdings), Inc. released its earnings results on Mar 18, 2025. The company reported -HK$0.013 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.013.
Is CK Life Sciences International (Holdings), Inc. overvalued?
According to Wall Street analysts CK Life Sciences International (Holdings), Inc.’s price is currently Overvalued.
Does CK Life Sciences International (Holdings), Inc. pay dividends?
CK Life Sciences International (Holdings), Inc. pays a Annually dividend of HK$0.008 which represents an annual dividend yield of N/A. See more information on CK Life Sciences International (Holdings), Inc. dividends here
What is CK Life Sciences International (Holdings), Inc.’s EPS estimate?
CK Life Sciences International (Holdings), Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does CK Life Sciences International (Holdings), Inc. have?
CK Life Sciences International (Holdings), Inc. has 9,611,072,000 shares outstanding.
What happened to CK Life Sciences International (Holdings), Inc.’s price movement after its last earnings report?
CK Life Sciences International (Holdings), Inc. reported an EPS of -HK$0.013 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 5.263%.
Which hedge fund is a major shareholder of CK Life Sciences International (Holdings), Inc.?
Currently, no hedge funds are holding shares in HK:0775
CK Life Sciences International (Holdings), Inc. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
169.56%
12-Months-Change
Fundamentals
Return on Equity
-3.29%
Trailing 12-Months
Asset Growth
-4.08%
Trailing 12-Months
Company Description
CK Life Sciences International (Holdings), Inc.
CK Life Sciences International (Holdings), Inc. (0775) is a biotechnology company primarily engaged in the research and development, manufacturing, and commercialization of products focused on the nutraceutical and pharmaceutical sectors. The company operates through two main business segments: healthcare, which includes pharmaceuticals and nutraceuticals, and agriculture-related businesses. CK Life Sciences is committed to improving human health and wellness through its innovative solutions and sustainable practices.
Technical Analysis
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
―
HBM Holdings Ltd.
―
Ascletis Pharma, Inc.
―
Ocumension Therapeutics
―
Ownership Overview
―
Insiders
0.15%
Mutual Funds
― Other Institutional Investors
99.80% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---